Base, variable, ESOP — and the one most committees under-weight
At VP level the parent ESOP can carry more of the deal than the cash. If you’re competing without one, splitting the difference loses the candidate.
Draft. Figures marked like this are illustrative and pending verification against Recruise placement data & Sachith sign-off before publication.
Key takeaways
- At VP level the deal is three instruments — base, variable and equity — and the parent ESOP is the one committees consistently under-weight.
- For senior candidates the equity line can carry more of the perceived value than the cash, especially against a listed or pre-IPO parent.
- If you can’t offer equity, splitting the difference in cash rarely closes the gap — you have to compete on a different axis.
The equity line is where senior offers are actually won or lost.
Committees are fluent in base and disciplined about variable. Where the reasoning gets thin is equity. At VP level in pharma and engineering-R&D GCCs, a grant against a strong listed or pre-IPO parent isn’t a garnish on the cash — for the right candidate it can be the largest and most motivating part of the package, precisely because it ties them to something larger than the local mandate. Yet it is routinely treated as a rounding item, sized late and explained badly.
The candidates worth hiring at this level do this maths carefully. They discount for vesting, for liquidity, for the parent’s trajectory. A grant that’s presented as an afterthought gets discounted to near zero in their heads; the same grant, framed as a real stake in a real story, can be worth a meaningful multiple of the annual cash in how they weigh the move.
“At VP level, cash gets you to the table and equity gets you the signature. The committees that lose these hires are the ones that argued hardest about base and shrugged at the grant.”
Sachith Rai · MD & Founder, Recruise
If you can’t offer equity, don’t try to buy your way past it.
Some centres genuinely can’t extend a parent grant to a local hire. The instinct is then to close the gap in cash — to split the difference and hope. It rarely works. A candidate weighing an equity story against a cash top-up isn’t comparing two numbers; they’re comparing an upside they can imagine against a certainty they can already get elsewhere. Cash loses that framing more often than the spreadsheet predicts.
The move is to change the axis. Compete on scope, on the mandate’s ownership, on the path to a role the equity-rich competitor can’t offer. If the deal has to be cash-only, it has to win on what the money buys the candidate to do — not on the money itself.
One pattern worth knowing, every week.
The Signal is our weekly read on the senior GCC talent market — one chart, one pattern, no noise. Written from live placement data.
More from Recruise Insights.
The AI/ML salary band just snapped in two
The top of band hasn't moved — it has split. Two markets now operate side by side, and most benchmarks still price them as one.
The hidden cost of paying at the 75th percentile
It sounds defensible. It’s also why your offer-accept rate is slipping. The real benchmark isn’t where you think.
The published band and the closed offer are two different numbers
One is written by people not running mandates. The other is what the candidate actually signs. Only one of them should set your budget.